Prelude Therapeutics
PRLD
#9186
Rank
$71.54 M
Marketcap
$1.30
Share price
46.40%
Change (1 day)
-69.12%
Change (1 year)

Prelude Therapeutics (PRLD) - Cash on Hand

Cash on Hand as of September 2024 : $0.15 Billion USD

According to Prelude Therapeutics's latest financial reports the company has $0.15 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Prelude Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.23 B15.47%
2022-12-31$0.20 B-30.73%
2021-12-31$0.29 B33.4%
2020-12-31$0.21 B1056.36%
2019-12-31$18.87 M21.06%
2018-12-31$15.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.27 B 77.29%๐Ÿ‡บ๐Ÿ‡ธ USA